Su-11274 is a selective Met tyrosine kinase inhibitor with IC50 of 10 nM. Su-11274 increases tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation. Su-11274 suppresses proliferation and motility of pancreatic cancer cells. Su-11274 enhances the response of the prostate cancer cell line DU145 to ionizing radiation. Su-11274 exhibits a selective inhibition pattern toward different receptor mutated variants.
Puffer:
Powder
CAS Nummer:
[658084-23-2]
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten